annual CFF:
$241.00K-$2.00M(-89.27%)Summary
- As of today (May 29, 2025), ADPT annual cash flow from financing activities is $241.00 thousand, with the most recent change of -$2.00 million (-89.27%) on December 31, 2024.
- During the last 3 years, ADPT annual CFF has fallen by -$26.91 million (-99.11%).
- ADPT annual CFF is now -99.92% below its all-time high of $319.92 million, reached on December 31, 2019.
Performance
ADPT Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$5.45M+$5.32M(+4192.13%)Summary
- As of today (May 29, 2025), ADPT quarterly cash flow from financing activities is $5.45 million, with the most recent change of +$5.32 million (+4192.13%) on March 31, 2025.
- Over the past year, ADPT quarterly CFF has increased by +$5.41 million (+12288.64%).
- ADPT quarterly CFF is now -98.29% below its all-time high of $319.55 million, reached on September 30, 2019.
Performance
ADPT quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$5.65M+$5.41M(+2243.57%)Summary
- As of today (May 29, 2025), ADPT TTM cash flow from financing activities is $5.65 million, with the most recent change of +$5.41 million (+2243.57%) on March 31, 2025.
- Over the past year, ADPT TTM CFF has increased by +$4.03 million (+249.29%).
- ADPT TTM CFF is now -98.30% below its all-time high of $332.59 million, reached on June 30, 2020.
Performance
ADPT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ADPT Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.3% | +10000.0% | +249.3% |
| 3 y3 years | -99.1% | +98.3% | -63.0% |
| 5 y5 years | -99.9% | +9.9% | -98.3% |
ADPT Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.8% | at low | -95.7% | >+9999.0% | -95.8% | +3073.0% |
| 5 y | 5-year | -99.9% | at low | -98.0% | >+9999.0% | -98.3% | +3073.0% |
| alltime | all time | -99.9% | at low | -98.3% | +462.4% | -98.3% | +640.5% |
ADPT Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $5.45M(+4192.1%) | $5.65M(+2243.6%) |
| Dec 2024 | $241.00K(-89.3%) | $127.00K(+217.5%) | $241.00K(+19.9%) |
| Sep 2024 | - | $40.00K(+33.3%) | $201.00K(+12.9%) |
| Jun 2024 | - | $30.00K(-31.8%) | $178.00K(-89.0%) |
| Mar 2024 | - | $44.00K(-49.4%) | $1.62M(-28.0%) |
| Dec 2023 | $2.25M(-98.3%) | $87.00K(+411.8%) | $2.25M(+3.7%) |
| Sep 2023 | - | $17.00K(-98.8%) | $2.16M(-98.3%) |
| Jun 2023 | - | $1.47M(+118.6%) | $127.67M(-1.9%) |
| Mar 2023 | - | $672.00K(>+9900.0%) | $130.19M(-1.6%) |
| Dec 2022 | $132.26M(+387.2%) | $6000.00(-100.0%) | $132.26M(-2.4%) |
| Sep 2022 | - | $125.52M(+3045.9%) | $135.54M(+947.2%) |
| Jun 2022 | - | $3.99M(+45.1%) | $12.94M(-15.3%) |
| Mar 2022 | - | $2.75M(-16.1%) | $15.28M(-43.7%) |
| Dec 2021 | $27.15M | $3.28M(+12.0%) | $27.15M(-9.9%) |
| Sep 2021 | - | $2.93M(-53.8%) | $30.12M(-90.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $6.33M(-56.7%) | $303.23M(-0.0%) |
| Mar 2021 | - | $14.61M(+133.7%) | $303.24M(+3.3%) |
| Dec 2020 | $293.59M(-8.2%) | $6.25M(-97.7%) | $293.59M(+1.6%) |
| Sep 2020 | - | $276.04M(+4256.0%) | $289.08M(-13.1%) |
| Jun 2020 | - | $6.34M(+27.8%) | $332.59M(+2.4%) |
| Mar 2020 | - | $4.96M(+184.0%) | $324.75M(+1.5%) |
| Dec 2019 | $319.92M(>+9900.0%) | $1.75M(-99.5%) | $319.92M(+0.5%) |
| Sep 2019 | - | $319.55M(<-9900.0%) | $318.45M(<-9900.0%) |
| Jun 2019 | - | -$1.50M(-1312.9%) | -$1.04M(-215.5%) |
| Mar 2019 | - | $124.00K(-55.4%) | $905.00K(-27.5%) |
| Dec 2018 | $1.25M(-97.5%) | $278.00K(+387.7%) | $1.25M(+28.7%) |
| Sep 2018 | - | $57.00K(-87.2%) | $970.00K(+6.2%) |
| Jun 2018 | - | $446.00K(-4.5%) | $913.00K(+95.5%) |
| Mar 2018 | - | $467.00K | $467.00K |
| Dec 2017 | $50.03M | - | - |
FAQ
- What is Adaptive Biotechnologies annual cash flow from financing activities?
- What is the all time high annual CFF for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual CFF year-on-year change?
- What is Adaptive Biotechnologies quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly CFF year-on-year change?
- What is Adaptive Biotechnologies TTM cash flow from financing activities?
- What is the all time high TTM CFF for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM CFF year-on-year change?
What is Adaptive Biotechnologies annual cash flow from financing activities?
The current annual CFF of ADPT is $241.00K
What is the all time high annual CFF for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual cash flow from financing activities is $319.92M
What is Adaptive Biotechnologies annual CFF year-on-year change?
Over the past year, ADPT annual cash flow from financing activities has changed by -$2.00M (-89.27%)
What is Adaptive Biotechnologies quarterly cash flow from financing activities?
The current quarterly CFF of ADPT is $5.45M
What is the all time high quarterly CFF for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly cash flow from financing activities is $319.55M
What is Adaptive Biotechnologies quarterly CFF year-on-year change?
Over the past year, ADPT quarterly cash flow from financing activities has changed by +$5.41M (+12288.64%)
What is Adaptive Biotechnologies TTM cash flow from financing activities?
The current TTM CFF of ADPT is $5.65M
What is the all time high TTM CFF for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM cash flow from financing activities is $332.59M
What is Adaptive Biotechnologies TTM CFF year-on-year change?
Over the past year, ADPT TTM cash flow from financing activities has changed by +$4.03M (+249.29%)